STACEY LACEY: Open Payments
NPI 1679946008 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 19 payments from 11 companies in 2025. Trend: 2023 $895 · 2024 $1,327 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $85 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Dexcom, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $33 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Wegovy, Dexcom G6 Transmitter, Ozempic, INJECTAFER, XIFAXAN, NURTEC ODT, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
